Sign in

CIK 0001750149

  • Non-accelerated filer
  • Smaller reporting company

Inhibikase Therapeutics, Inc.

Sign in to watch
Ticker
IKT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
263407249
Phone
+1 302-295-3800
Business address
1000 N. WEST STREET, SUITE 1200, WILMINGTON, DE, 19801
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-02-21 Cabell Christopher President & Head of R&D Returned to the company −338,282 676,564
2026-01-05 Cabell Christopher President & Head of R&D Grant or award · Stock Option (Right to Buy) +900,117 900,117
2025-02-21 Cabell Christopher President & Head of R&D Grant or award · Stock Option (Right to Buy) +1,100,705 1,100,705
2025-02-21 Cabell Christopher President & Head of R&D Grant or award · Stock Option (Right to Buy) +1,100,705 1,100,705

Page 1 of 1 · 4 trades